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BACKGROUND: On theoretical grounds, the age of the grandmother and the age of the mother at delivery of her daughter may affect
the breast cancer risk of the granddaughter.
METHODS: We used the data relating to the Diagnostic Research Mamma-carcinoma cohort (DOM (Diagnostisch Onderzoek
Mammacarcinoom) 3), which comprises a population-based sample of 12178 women aged 41–63 years at enrolment in 1982–85
and followed up until 2000. During follow-up 340 postmenopausal breast cancer cases were identified. To these we applied a case–
cohort design together with a random sample from the baseline cohort (n¼1826). Of these study participants, we were able to
retrieve the birth dates of 998 mothers (309 cases, 689 controls), and for 547 of these we also retrieved the birth dates of the
grandmothers (197 cases, 350 controls). A weighted Cox proportional hazards model was used to estimate the hazard ratios (HRs)
for the effect of the age of the grandmother and the age of the mother on the breast cancer risk of the index women, while adjusting
for potential confounders.
RESULTS: Compared with the reference group aged 25–29.9 years, the group with the lowest maternal age (o25 years) had an age-
adjusted HR of 0.77 (95% CI 0.19–3.12) and the group with the highest maternal age (X40 years) had an age-adjusted HR of 1.58
(95% CI 0.01–267.81), P-value for trend¼0.62. Compared with the same reference group, the group with the lowest grandmaternal
age (o25 years) had an age-adjusted HR of 0.53 (95% CI 0.24–1.17) and the group with the highest grandmaternal age (X40 years)
had an age-adjusted HR of 7.29 (95% CI 1.20–44.46), P for trend¼0.04. The associations did not change significantly after additional
adjustment for various risk factors for breast cancer, neither for maternal age nor for grandmaternal age.
CONCLUSION: This study does not suggest a major role of maternal age at delivery or grandmaternal age at delivery of the mother for
the (grand)daughters’ breast cancer risk.
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Breast cancer is the commonest cancer in women worldwide.
Several studies show breast cancer risk to increase with
characteristics that can be considered as proxy of early-life events,
such as higher paternal and maternal age (Xue et al, 2007).
Besides hypotheses on the role of post-conception (intrauterine)
early-life events, a pre-conception hypothesis on the quality of the
oocyte during conception as a risk factor for adult breast cancer
has also been put forward (Trichopoulos, 1990; van Noord, 2002).
The viability of the oocyte seems to be co-determined by the
quality of its mitochondria and their energy/ATP production,
which declines with age (Papa, 1996; Ozawa, 1997).
Suboptimal energy production by less viable mitochondria may,
for example, affect the correct functioning of the cell spindle
required for proper chromosome separation during the first five
cell divisions. Aberrant spindle function may result either in
spontaneous abortion, or, when the fertilised egg survives, in (a
higher propensity to) aneuploidy in the fetus and related birth
defects which might not be directly noticeable at birth.
Mitochondria are passed on from mother to child only;
therefore, a high maternal age (resulting in less viable mitochon-
dria) might increase the risk of several cancers in the offspring
(Deusberg et al, 1998; Van Noord, 2002, 2003). Consequently, there
may be trans-generational effects, because mitochondria are
passed on from mother to daughter to granddaughter (Van
Noord-Zaadstra et al, 1991).
We explored whether there is a relation between grandmother’s
age at birth of the mother and breast cancer risk of the index
woman, and whether there is a relation between the mother’s age at
birth of the index woman, and breast cancer risk of the index
woman, using data from the Dutch DOM (Diagnostisch Onderzoek
Mammacarcinoom) cohort.
MATERIALS AND METHODS
The DOM cohort consists of 55519 women, born between 1911 and
1945, who participated voluntarily in a population-based breast
cancer screening project (DOM project). The participants were
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Netherlands between 1974 and 1986. Depending on their year of
birth they were included in one of the four distinct cohorts, each of
which completed different questionnaires. For the purpose of this
study, we used the data of the third cohort consisting of 12178
women, born in 1932–41 and recruited in 1982–85. For these
women data were available on early-life characteristics and on the
most important reproductive risk factors for breast cancer. The
design and methodology of the DOM project has been described
previously (De Waard et al, 1984). To prevent a costly and time-
consuming assessment of vital status during follow-up, the
efficiency of a case–cohort study design was chosen, in which a
random sample of the total cohort is used to represent the total
person-years lived for the entire cohort (Barlow et al, 1999). We
selected at random a sample of approximately 15% of the total
cohort (n¼1826), which was followed up until 1 January 2000, by
using regional municipality registries for mortality and movement
out of the catchment area of the cancer registry.
In the Netherlands, the Central Bureau for Genealogy (CBG)
preserves the personal data of deceased persons. These data were
primarily collected by the municipal registries: this was by hand on
a hardcopy card from 1938–39 onwards until this was compu-
terised in 1994. For each Dutch citizen born before 1994 a personal
hardcopy card is stored containing the name, date of birth,
nationality, names and birth dates of the parents. In 1994 the
personal hardcopy card was replaced by a digital personal record.
All persons still living have a digital personal record, which is not
yet available at the CBG. We collected these data of the DOM
participants using the electronic database of the national
municipal administration registration (GBA). In addition, we
collected the personal record cards of the mother of the DOM
participants, containing the birth dates of the grandparents.
Maternal and grandmother’s age at delivery were calculated by
subtracting the DOM woman’s date of birth from the (grand)-
maternal date of birth. Women with missing data on year of birth
or on the year of birth of their (grand)mother were excluded.
Through genealogical research we were able to retrieve the birth
dates of 998 mothers (309 cases, 689 controls) and 547 grand-
mothers (197 cases, 350 controls). For 547 subjects (197 cases, 350
controls), we had complete maternal and grandmaternal birth
data. The study was approved by the Institutional Review Board of
UMC Utrecht.
At recruitment, 72% of the participants were not yet post-
menopausal. During follow-up, for some women updated informa-
tion on menopausal status and age was collected, and this
information was used in the analysis. If it was missing (n¼436)
we imputed the menopausal status at age 52 for smokers and at age
55 for non-smokers (Parente et al, 2008). Pre-menopausal breast
cancer cases were excluded from the analyses.
We identified all primary invasive breast cancers (n¼435) that
occurred until 1 January 2000 in the DOM-3 cohort. The DOM
project started as a mammographical breast cancer screening
project, which was set up to assess its effect on breast cancer
occurrence and mortality. For this an active registration team was
set up, evolving into the regional cancer registry, which has
become complete for the detection of all cancers from 1987
onwards. It is one of the eight comprehensive cancer centres in the
Netherlands that together form the national cancer registry that is
part of the international databank of the IARC (International
Agency of Cancer Research) and the European databank of the
ENCR (European Network Cancer Registration) (http://
www.ikc.nl). From 1989 onwards, the DOM database is linked to
the regional cancer registry on an annual basis to identify all new
breast cancer cases within the DOM cohort.
Many potential risk factors for breast cancer were assessed
through the questionnaires. As in other studies, the risk factors we
considered were as follows: age, premature birth, birth order
(firstborn), birth weight and birth length, adult height, weight at age
18, current weight at baseline, alcohol consumption, physical activity
in leisure time, age at menarche, age at menopause, menopausal
status at diagnosis, ever oral contraceptive use, ever postmenopausal
hormone use, age at first birth, parity, history of benign breast
disease and family history of breast cancer among first-degree
relatives. In addition, we also considered the number of months of
full lactation during the lifetime (Xue and Michels, 2007).
Statistical analysis
To establish the possible association between breast cancer risk of
the (grand)daughter and (grand)maternal age at the time her
daughter was born, we used weighted Cox regression analyses. The
methods for these analyses are largely similar to a standard Cox
regression and are well described (Barlow et al, 1999). Follow-up
time ended at the date of the breast cancer diagnosis. Women who
remained free of breast cancer during the observation period were
censored at the date of movement, date of death or on 1 January
2000, whichever occurred first. Analyses were done with SAS
version 8.2 by use of a weighted Cox regression macro (available at
http://lib.stat.cmu.edu/general /robphreg) that computes the
weighted hazard ratios together with robust s.e.’s, which we used
to calculate the 95% confidence intervals. We fitted both age-
adjusted and covariate-adjusted Cox proportional hazard models.
We analysed the effect of maternal age on breast cancer in 998
DOM participants by fitting four models: in the first we adjusted
for age only, the second takes account of age and all breast cancer
risk factors, the third adjusts for age and age of the grandmother
(n¼547 women), the final model adjusts for age, age of the
grandmother and all breast cancer risk factors (n¼547). We
analysed the effect of grandmaternal age on breast cancer risk in
the granddaughter by fitting again four models as above, now in
547 DOM women. Both maternal and grandmaternal ages were
categorised as o25, 25–29.9, 30–34.9, 35–39.9 and X40 years.
We chose grandmaternal age 25–29.9 years as the reference group
in all models, because this was the largest group in both variables.
Trend tests were performed with midpoints of categories.
The covariate-adjusted model included the characteristics of
intrauterine exposures, namely birth weight, birth length, pre-
maturity and firstborn. Furthermore, this model was adjusted for
the following risk factors: alcohol (categorised as never, sometimes
or often), BMI (categorised as o20, 20–25, 25–30, 30–35 and
X35kgm
 2), postmenopausal HRT use (ever/never), a positive
history of benign breast disease (dysplasia) (yes/no), a positive
family history of breast cancer (yes/no) and age at first delivery
(categorised as o25, 25–29.9 and X30 years or as an indicator
variable if nulliparous), parity (categorised as 0, 1, 2, 3 or X4
years) and age at menopause (continuous). Missing data for each
covariate were analysed as indicator variables in the model.
RESULTS
In 1982–2000, 435 breast cancer cases occurred in the whole
DOM3 cohort (n¼12178), of which 340 cases were postmeno-
pausal. The 1826 participants in the random sample, including all
breast cancer cases, contributed 25906 person-years. The dis-
tribution of most personal characteristics of the participants for
whom we knew the age of the mother (n¼998) did not differ
across the categories of maternal age at delivery, but women whose
mother was older at delivery were more likely to be prematurely
delivered, to have a family history of breast cancer, to be slightly
older at first childbirth, to have a slightly lower BMI, and to drink
more alcohol, and less likely to be firstborn (Table 1). The
distribution of these characteristics among the participants for
whom we knew the age of the grandmother (n¼547) showed the
same pattern, except for family history, which was less likely to be
present when the grandmother was older at delivery.
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minimum age of 16.8 and a maximum age of 47.9 years. The mean
grandmaternal age at delivery of the mother of the index woman
was 31.0 years, with a minimum age of 18.4 years and a maximum
age of 50.8.
In age-adjusted analysis, maternal age was not associated with
breast cancer risk (P for trend¼0.62). When compared with the
reference group of maternal age 25–29.9 years, the group with the
lowest maternal age (o25 years) had an age-adjusted hazard ratio
(HR) of 0.77 (95% CI 0.19–3.12), and the group with the highest
maternal age (X40 years) showed a HR of 1.58 (95% CI 0.01–
267.81) (Table 2). The association did not change after additional
adjustment for characteristics as proxy for intrauterine exposures
or breast cancer risk factors (P for trend¼0.76).
Grandmaternal age showed a borderline significant association
with the breast cancer risk of the granddaughter after adjustment
Table 1 Distribution of personal characteristics across levels of (grand)maternal age at delivery in the DOM study at baseline in 1982–85 (n participants
with known maternal age¼14660 person-years, n participants with known grandmaternal age¼7938 person-years)
Maternal age at delivery (years) Grandmaternal age at delivery (years)
Personal characteristics o25 25–29 30–34 35–39 X40 o25 25–29 30–34 35–39 X40
Age (year): mean 46.6 46.2 46.6 46.4 46.4 46.4 46.6 46.1 46.5 45.7
Birth weight (g): mean 3563 3467 3227 3320 3514 3111 3385 3439 3415 3246
Premature (%) 8.6 13.5 10.7 10.2 14.3 8.8 12.7 13.1 11.4 30.0
Firstborn (%) 65.6 43.6 18.0 7.4 4.2 30.6 32.5 32.0 25.5 36.0
Height (m): mean 1.65 1.66 1.66 1.65 1.65 1.65 1.66 1.66 1.64 1.65
BMI (kgm
 2): mean 25.0 25.0 24.7 24.6 24.3 25.6 24.9 24.7 24.5 24.1
Age at first birth (years): mean 24.6 25.4 25.2 25.6 25.8 25.1 25.7 25.1 25.4 25.2
Parity
Nulliparous (%) 12.0 12.7 12.7 18.5 6.9 8.2 16.9 7.5 16.3 10.0
Parous: mean 2.7 2.6 2.7 2.7 2.7 2.7 2.7 2.6 2.7 2.5
Alcohol (%)
Never 19.1 15.6 19.1 18.5 16.7 22.5 22.7 16.3 12.2 14.0
Sometimes 19.1 15.0 14.6 14.8 19.4 19.4 16.2 10.9 16.3 6.0
Often 61.8 69.4 66.3 66.7 63.9 58.2 61.0 72.8 71.4 80.0
Dysplasia (%) 23.5 35.0 33.2 33.8 38.9 33.7 27.9 37.2 34.7 42.0
Age at menarche (years): mean 13.3 13.5 13.6 13.5 13.4 13.6 13.6 13.6 13.6 13.3
Menopausal status (%)
Pre 13.4 21.8 18.7 11.7 5.4 13.5 21.0 19.2 12.6 7.5
Post 4.9 9.6 8.0 4.5 1.8 4.4 7.1 7.7 5.3 1.2
Family history positive (%) 6.0 7.0 11.6 9.3 18.1 7.2 13.3 8.3 11.6 8.3
Number of women included
in analysis
183 314 267 162 72 98 154 147 98 50
Abbreviation: DOM¼Diagnostisch Onderzoek Mammacarcinoom.
Table 2 Maternal and grandmaternal age at delivery vs the incidence of breast cancer in the (grand)daughter, during follow-up from 1982 to 2000 among
participants of the DOM study
No. of
cases
Person-
years
Crude HR
(95% CI)
Age-adjusted
HR (95% CI)
Covariate-adjusted
HR (95% CI)
a
Age+covariate-adjusted
b
HR (95% CI)
Maternal age (years) n¼998 n¼547
o25 53 2679 0.90 (0.61–1.33) 0.77 (0.19–3.12) 0.87 (0.59–1.28) 0.95 (0.23–3.82)
25–29.9 97 4634 1.00 1.00 1.00 1.00
30–34.9 90 3915 1.11 (0.79–1.56) 1.29 (0.25–6.57) 0.95 (0.57–1.58) 1.06 (0.42–2.68)
35–39.9 46 2389 0.87 (0.58–1.31) 1.18 (0.04–36.04) 0.72 (0.30–1.68) 0.55 (0.11–2.84)
X40 23 1043 1.00 (0.59–1.70) 1.58 (0.01–267.81) 0.92 (0.36–2.33) 0.47 (0.10–2.24)
P for trend 0.75 0.62 0.76 0.86
Grandmaternal age (years) n¼547
o25 33 1423 0.89 (0.53–1.50) 0.53 (0.24–1.17) 0.86 (0.41–1.80) 0.84 (0.39–1.79)
25–29.9 55 2260 1.00 1.00 1.00 1.00
30–34.9 44 2168 0.76 (0.48–1.22) 1.24 (0.59–2.64) 0.67 (0.26–1.72) 0.71 (0.27–1.88)
35–39.9 41 1379 1.30 (0.78–2.16) 3.53 (1.00–12.41) 1.36 (0.42–4.36) 1.50 (0.46–4.86)
X40 24 708 1.62 (0.87–3.00) 7.29 (1.20–44.46) 1.22 (0.25–5.92) 1.45 (0.27–7.81)
P for trend 0.23 0.05 0.89 0.83
Abbreviations: CI¼confidence interval; DOM¼Diagnostisch Onderzoek Mammacarcinoom; HR¼hazard ratios.
aHazard ratio and 95% CI adjusted for alcohol, dysplasia, BMI
at inclusion, no. of months breastfeeding, no. of times X7 months pregnant, age at first childbirth, premature, birth weight, birth length, firstborn, HRT use, menarche, menopausal
age, familial breast cancer.
bHazard ratio and 95% CI: maternal age adjusted for grandmaternal age and covariates, grandmaternal age adjusted for maternal age and covariates.
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group of grandmaternal age 25–29.9 years, the group with the
lowest grandmaternal age (o25 years) had an age-adjusted HR of
0.53 (95% CI 0.24–1.17) and the group with the highest grand-
maternal age (X40 years) had an age-adjusted HR of 7.29 (95% CI
1.20–44.46) (Table 2). After adjusting for further confounders, the
association between grandmaternal age and breast cancer risk was
no longer significant (P for trend¼0.89); HR for the group with
the highest maternal age (X40 years) was 1.22 (95% CI 0.25–5.92).
When maternal and grandmaternal age were combined in one
model, there was again no evidence for a relation between
grandmother’s age at birth of the mother and breast cancer risk
of the index woman, nor for a relation between the mother’s age at
birth of the index woman and breast cancer risk of the index
woman. Owing to the limited sample size, we were not able to
stratify for the birth order, menopausal status, or family history.
We did not have detailed nutritional information of the
participants, but we did ask for daily milk consumption and for
the type of milk that was consumed (categorised as o1 per day,
1–2 per day or 42 per day and categorised as no milk, skimmed
milk, half-full milk, varies, or full-fat milk). Although relations
with breast cancer are not consistent (Cho et al, 2003), we also ran
models including this variable, but the effects did not change.
DISCUSSION
In this prospective cohort study, we did not observe an association
between grandmaternal or maternal age and breast cancer risk
among their granddaughters. To our knowledge, this is the first
study, in which the association between grandmothers’ age at
delivery of the mother and breast cancer in the daughter is explored.
At least 7 cohort studies (Holmberg et al, 1995; Zhang et al, 1995;
Mogren et al, 1999; Hemminki and Kyyronen, 1999; Hilakivi-Clarke
et al, 2001; McCormack et al, 2003; Xue and Michels, 2007) and 14
case–control studies (see below for references) have examined
maternal age at delivery in relation to breast cancer risk, with
inconsistent results. The largest cohort study found a positive
relation for women with mothers’ age over 40 but no linear trend
between the age of the mother and breast cancer (Holmberg et al,
1995). The second largest study observed a moderate positive
relation with maternal age (Xue and Michels, 2007), whereas two
studies found a non-significant positive association (Zhang et al,
1995; Mogren et al, 1999). The other three studies showed no
association with maternal age (Hemminki et al, 1999; Hilakivi-
Clarke et al,2 0 0 1 ;M c C o r m a c ket al, 2003). Of the 14 case–control
studies, 5 report a significant positive association between maternal
age and breast cancer (Rothman et al,1 9 8 0 ;J a n e r i c het al, 1989;
Thompson and Janerich, 1990; Innes et al, 2002; Hodgsen et al,
2004), 3 studies report a non-significant positive association
(Ekbom et al,1 9 9 7 ;C h o iet al, 2005; Park et al, 2006) and 6 studies
do not find an association between maternal age and breast cancer
risk (Le Marchand et al,1 9 8 8 ;S a n d e r s o net al, 1996; Newcomb et al,
1997; Weiss et al, 1997; Titus-Ernstoff et al, 2002; Mellemkjaer et al,
2003). Reasons for the inconsistencies in results may include the
variety in study designs or study populations.
Several of these studies assessed maternal age by recall of the
daughter, which is likely to be less accurate than through birth
certificates as in our study. In addition, some studies only had
information on characteristics that we consider a proxy for intra-
uterine exposure, but lacked information on risk factors acting
later in life. Two cohort studies collected prospective information
about adult risk factors for breast cancer through questionnaires,
in addition to retrospective information (Zhang et al, 1995; Xue
and Michels, 2007); both found a positive relation with maternal
age. The remaining cohort studies mainly used retrospective
information regarding childhood factors in their analyses and were
therefore not able to adjust for adult risk factors (Holmberg et al,
1995; Hemminki and Kyyronen, 1999; Mogren et al, 1999; Hilakivi-
Clarke et al, 2001; McCormack et al, 2003).
As we were unable to find any association between (grand)maternal
age and breast cancer risk in the offspring, our hypothesis may be
‘incorrect’. There is evidence that oocyte quality declines with
increasing maternal age at conception, especially after age 30 (Van
Noord-Zaadstra et al, 1991), owing to quality loss of its mitochondria
(Papa, 1996; Ozawa, 1997). It is also known that mitochondria are
passed on from mother to child. This might suggest a threshold effect
rather than a linear relation with age. Nevertheless, we found no
evidence for a threshold effect: for women over age 30 at first delivery,
the risk of breast cancer in their daughters was lower than in younger
mothers, but not statistically significantly. We hypothesised that the
v i a b i l i t yo fm i t o c h o n d r i ad e p e n d son grandmaternal age. We adjusted
for many known and several less well-known risk factors for breast
cancer, but the number of patients with complete information on birth
dates limited the power of our study, and preventing subgroup analyses
on modification by menopausal status, birth order or family history. Of
the four largest cohort studies, three suggested a positive association
between maternal age and breast cancer risk in daughters (Holmberg
et al, 1995; Mogren et al, 1999; Xue and Michels, 2007).
Although we were able to adjust for most of the known risk
factors of breast cancer, we were not able to correct the results for
physical activity and oral contraceptive use because these variables
had a large number of missing values.
Our study has several strengths. We used documented informa-
tion about birth data instead of recalled information to calculate
(grand)mothers’ age at childbirth. In addition, the main purpose of
the DOM study was to evaluate the risk factors of breast cancer,
thereby allowing the possibility of adjusting for most of these,
whereas five of the seven other cohort studies were unable to
adjust for several important adult risk factors.
In summary, in this prospective follow-up study over an 18-year
period, no significant association between (grand)maternal age at
delivery and breast cancer risk of their (grand)daughter was found.
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